Navigation Links
SCPC Backs Bipartisan Senate, House Bills to Eliminate Retroactive PBM Middlemen Fees on Patients, LTC Pharmacies, Medicare Program
Date:2/22/2017

WASHINGTON, Feb. 22, 2017 /PRNewswire-USNewswire/ -- The Senior Care Pharmacy Coalition (SCPC) today backed legislation introduced in the U.S. Senate and House of Representatives that will curtail the ability of drug industry middlemen -- Pharmacy Benefit Managers (PBMs) -- from extracting retroactive direct and indirect remuneration (DIR) fees in transactions with patients, long term care (LTC) pharmacies and the Medicare program.

S. 413, introduced by Sens. Shelley Moore Capito (R-WV) and Jon Tester (D-MT), and House companion bill, H.R. 1038, introduced by Reps. Morgan Griffith (R-VA) and Peter Welch (D-VT), specifically prohibits pharmacy DIR fees from being applied after the point of sale for prescription medications dispensed to Medicare patients. Alan G. Rosenbloom, President of SCPC, says passage of the bills into law will begin to address DIR fee abuses -- and other unfair practices such as "switching fees" -- that negatively affect patients, LTCPs and the Medicare program itself.

S. 413 sponsors are Sens. John Boozman (R-AR), Tom Cotton (R-AR), Charles Grassley (R-IA), Heidi Heitkamp (D-ND), James Lankford (R-OK) and Roger Wicker (R-MS).

H.R. 1038 sponsors are Reps. Bruce Babin (R-TX), Lou Barletta (R-PA), Rod Blum (R-IA), Buddy Carter (R-GA), Doug Collins (R-GA), Rick Crawford (R-AR), Lloyd Doggett (D-TX), Drew Ferguson (R-GA), Bob Goodlatte (R-VA), Gregg Harper (R-MS), Walter Jones (R-NC), Thomas Massie (R-KY), Cathy McMorris Rodgers (R-WA), Martha Roby (R-AL), Phil Roe (R-TN) and Pete Sessions (R-TX).

"We strongly support the bipartisan, bicameral effort to crack down on PBMs' ability to reach into the pockets of elderly patients and LTC pharmacies weeks and even months following a prescription drug transaction," Rosenbloom said. "We will be working in the coming weeks with the sponsors and cosponsors of both bills to explain in more detail how PBM middlemen wrongly siphon resources from patients, providers and the Medicare program itself."

Rosenbloom noted the bill introductions follow a January 2017 Centers for Medicare & Medicaid Services (CMS) report finding that drug companies and pharmacies are paying larger rebates to PBMs and insurers, but that these PBMs are keeping the money rather than translating it into lower costs for government health care programs or beneficiaries.

CMS data show that since 2010, the growth in rebates or concessions paid by drug companies or pharmacies to PBMs or managed care plans (in addition to the lump sum payment plans received from Medicare) after the point of sale (DIR) has far outpaced the growth in Part D drug costs. The DIR that plans report to CMS increased from $31 billion in 2012, to $50 billion in 2015.

The SCPC is the national association for independent LTC pharmacies. Our member pharmacies provide care and services to patients in LTC facilities in across the country occupying approximately 675,000 beds across the country.  Visit us at www.seniorcarepharmacies.org to learn more. 

 

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/scpc-backs-bipartisan-senate-house-bills-to-eliminate-retroactive-pbm-middlemen-fees-on-patients-ltc-pharmacies-medicare-program-300411743.html


'/>"/>
SOURCE Senior Care Pharmacy Coalition
Copyright©2017 PR Newswire.
All rights reserved


Related medicine technology :

1. CEO of Cord Blood Bank Challenges Industry Executives to Stop Practice of Physician Kickbacks
2. Corporate Whistleblower Center Urges MDs to Call With Proof a Drug Company Is Providing Kickbacks to Physicians, as the Reward Potential is Substantial
3. Biomet to Pay Over $6 Million to Resolve Whistleblower Claims That It Paid Kickbacks to Doctors
4. Omnicare (NYSE: OCR) Agrees to Pay United States $120 Million to Settle False Claims Act Suit Alleging Kickbacks
5. Bipartisan Legislation Reintroduced to Improve Patient Access to Pharmacists Health Care Services
6. NCPA: Bipartisan Senate and House Letters Urge Medicare to Finalize Transparency Proposal
7. SCPC Praises Bipartisan Collins-Loebsack Letter Advancing Investigation of PBMs Anti-Competitive, Non-Transparent Pricing Practices
8. Ex-White House Drug Spokesman Robert Weiner And Daniel Sordello Assert "Rewriting Drug Policy" Bipartisan Presidential Campaign And Debate Issue
9. SCPC Praises Broad Bipartisan Support in U.S. House for 21st Century Cures Act
10. Bidding Fix Takes Major Step Forward After Bipartisan Vote of House Ways and Means Committee
11. PCMA Supports Bipartisan Legislation Creating Safe Pharmacy Networks to Reduce Prescription Drug Abuse in Medicare
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/16/2019)... ... 16, 2019 , ... Actuate Therapeutics, Inc., a clinical stage biopharmaceutical company, today ... Series B is led by Kairos Ventures, with DEFTA Partners, Tech Coast Angels, and ... to expand the company’s ongoing Phase 1 / 2 clinical trial and fund development ...
(Date:5/16/2019)... , ... May 16, 2019 , ... ... and Dr. Peter D. Caie, Senior Research Fellow at St. Andrew University, UK ... EDT (2pm BST/UK) to learn about a deep learning based image analysis solution ...
(Date:5/15/2019)... ... May 15, 2019 , ... E.M.M.A. ... compliance services for the Medical Device industry, will be participating in a panel ... growing digital device field. Also, EMMA International will be delivering a course on ...
Breaking Medicine Technology:
(Date:5/14/2019)... (PRWEB) , ... May 14, 2019 , ... ... make it 27 of 32 professional football teams in the U.S. who rely ... “Our customers depend on our hydrotherapy solutions to accelerate healing,” said Timothy McCarthy, ...
(Date:5/14/2019)... ... May 14, 2019 , ... ... in the following majors: Health Science, Exercise Science, Psychology, and Business. These changes ... deans, and Provost, in order to ensure that each program best suits students’ ...
(Date:5/14/2019)... (PRWEB) , ... May 14, 2019 , ... ... hold the key to solving the world’s biggest health issues – ‘big data’. ... Digital Health CRC (Cooperative Research Centre), Stanford University and Southern Methodist University ...
(Date:5/14/2019)... ... May 14, 2019 , ... ChoiceSpine LLC, a privately-held spinal ... Food and Drug Administration (FDA) to market TIGER SHARK C interbody device with ... use together or separately in cervical spinal fusion procedures. , “BOOMERANG is ...
(Date:5/14/2019)... ... May 14, 2019 , ... Survival rates decline every year ... to a new study. , For each year diagnosis is delayed, the risk of ... issue of the Journal of Oral and Maxillofacial Surgery – the official journal of ...
Breaking Medicine News(10 mins):